Acute brain ischemia is a dynamic process susceptible to multiple modulating factors, such as blood glucose level. During acute ischemic brain injury, hyperglycemia exacerbates multiple deleterious derangements. Timely and sufficient correction of hyperglycemia during acute brain ischemia may limit the brain injury and improve clinical outcomes. The clinical efficacy of such intervention remains to be proven. Although results from animal and clinical observational studies suggest that hyperglycemia during acute brain ischemia may exacerbate the brain injury, there is no evidence from randomized treatment trials that rapid correction of the hyperglycemia improves outcomes. Given the excess effort, cost, and risk involved in rapid and safe correction of hyperglycemia during acute stroke, less aggressive treatments with subcutaneous insulin seem appropriate at this time. Subcutaneous insulin protocols can maintain blood glucose levels below 200 mg/dL a majority of the time in most patients, especially if basal insulin is added. When available, an endocrinology consultant can optimize the acute treatment and help the transition to long-term care. Given the multiple reports linking admission hyperglycemia with symptomatic hemorrhagic conversion of ischemic stroke treated with thrombolytic drugs, it may be best to rapidly lower severe hyperglycemia in such patients. For example, if the admission blood glucose is approximately 300 mg/dL and the patient is a candidate for thrombolytic therapy, consider giving an intravenous bolus of regular insulin 8 units. Somewhat lower or higher insulin doses may be best for lesser or greater hyperglycemia. Such a bolus will start lowering the blood glucose in about 5 min. A temporary continuous intravenous insulin infusion may then be used in most patients to maintain the glucose closer to normal levels (eg, below 180 or 140 mg/dL).
Williams LS, Rotich J, Qi R, et al.: Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 2002, 59:67–71. PubMed
Whisnant JP, Wiebers DO, O’Fallon WM, et al.: A population-based model of risk factors for ischemic stroke: Rochester, Minnesota. Neurology 1996, 47:1420–1428. PubMed
de Courten-Myers G, Myers RE, Schoolfield L: Hyperglycemia enlarges infarct size in cerebrovascular occlusion in cats. Stroke 1988, 19:623–630. PubMed
Cheung NW, Wong VW, McLean M: The Hyperglycemia: Intensive Insulin Infusion In Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diab Care 2006, 29:765–770. CrossRef
Malmberg K, Ryden L, Efendic S, et al.: on behalf of the DIGAMI Study Group: Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995, 26:57–65. CrossRefPubMed
Gandhi GY, Nuttall GA, Abel MD, et al.: Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med 2007, 146:233–243. PubMed
Poppe AY, Majumdar SR, Jeerakathil T, et al.: Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis. Diab Care 2009, 32:617–622. CrossRef
Bruno A, Biller J, Adams Jr HP: et al.: Acute blood glucose level and outcome from ischemic stroke. Trial of Org 10172 in Acute Stroke Treatment (TOAST) investigators. Neurology 1999, 52:280–284. PubMed
Bruno A, Levine SR, Frankel MR, et al.: Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002, 59:669–674. PubMed
Demchuk AM, Morgenstern LB, Krieger DW, et al.: Serum glucose level and diabetes predict tissue plasminogen activator–related intracerebral hemorrhage in acute ischemic stroke. Stroke 1999, 30:34–39. PubMed
Kase CS, Furlan AJ, Wechsler LR, et al.: Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 2001, 57:1603–1610. PubMed
Davidson PC, Steed RD, Bode BW, et al.: Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120, 618 h of operation. Diab Care 2005, 28:2418–2423. CrossRef
Glycemic Control Resource Room Project Team: Insulin orders & protocols: IV insulin infusions. Available at www.Hospitalmedicine.Org/resourceroomredesign/html/12clinical_tools/04_insulin_ordersiv.Cfm. Accessed July 23, 2010.
- Diabetes Mellitus, Acute Hyperglycemia, and Ischemic Stroke
MD, MS Askiel Bruno
MD David Liebeskind
MD, PhD Qing Hao
MD Radoslav Raychev
for the UCLA Stroke Investigators
- Current Science Inc.